riluzole has been researched along with Myasthenia Gravis in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Longinetti, E | 1 |
| Sveinsson, O | 1 |
| Press, R | 1 |
| Ye, W | 1 |
| Ingre, C | 1 |
| Piehl, F | 1 |
| Fang, F | 1 |
| Restivo, DA | 1 |
| Bianconi, C | 1 |
| Ravenni, R | 1 |
| De Grandis, D | 1 |
2 other studies available for riluzole and Myasthenia Gravis
| Article | Year |
|---|---|
ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study.
Topics: Amyotrophic Lateral Sclerosis; Female; Humans; Male; Myasthenia Gravis; Neuroinflammatory Diseases; | 2022 |
ALS and myasthenia: An unusual association in a patient treated with riluzole.
Topics: Amyotrophic Lateral Sclerosis; Electrophysiology; Humans; Male; Middle Aged; Myasthenia Gravis; Neur | 2000 |